Orlando, FL -- (SBWIRE) -- 10/10/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Amgen, Inc.(NASDAQ:AMGN), Celgene Corporation (NASDAQ:CELG).
Amgen, Inc.(NASDAQ:AMGN) shares declined 1.37% to $106.28. The company on Oct. 4 announced that it will present data from several romosozumab and Prolia® (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013. Romosozumab data include results from the Phase 2 study that demonstrate significant increases in volumetric bone mineral density.
Additionally, Amgen and ShanghaiTech University on Sept. 24 announced the two organizations have entered into a memorandum of understanding (MOU) to form a strategic partnership for the advancement of biopharmaceutical discovery and translational research in China. This agreement includes plans for Amgen to open a China research and development (R&D) center at ShanghaiTech University.
Are investors worried about the recent updates with AMGN? Find out with a free trend analysis HERE
Celgene Corporation (NASDAQ:CELG) shares declined 1.12% to $146.87. PharmAkea Therapeutics, Inc. and Bay City Capital, LLC, on Oct. 4 announced a strategic collaboration with Celgene Corporation designed to leverage PharmAkea's proprietary drug discovery platform to generate and advance novel small-molecule therapies targeting cancer and fibrotic diseases. Under terms of the agreement, Celgene Corporation will commit $35 million to PharmAkea during an initial three-year alliance term, with an option to extend the collaboration with additional funding.
Additionally, the company will host a conference call and live audio webcast on Thursday, October 24, 2013 at 9 a.m. ET to discuss third quarter 2013 financial and operational results.
Moreover, the company will begin trading ex-dividend on October 08, 2013. A cash dividend payment of $6.932592 per share is scheduled to be paid on October 07, 2013. Shareholders who purchased CELGZ stock prior to the ex-dividend date are eligible for the cash dividend payment.
Is CELG going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)